Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Ett webbaserat program för att hjälpa vårdgivare till lungpatienter att lära sig om tillgängliga stödvårdsresurser (CONNECT)

23 september 2026 uppdaterad av: Wake Forest University Health Sciences

Multi-Site Community Onkologiplanering för CONNECT-interventionen inriktad på lungcancervårdare

Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.

Studieöversikt

Detaljerad beskrivning

This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.

Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:

  • After consenting and before randomization of participant and caregiver. (Initial survey)
  • Approximately 12 weeks after completing the first survey (12-week survey)
  • Approximately 24 weeks after completing the first survey (24-week survey)

Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.

Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:

  • Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
  • Group 2 will be provided with a generic supportive care resource list.
  • Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.

Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:

  • After consenting and before randomization of participant and caregiver. (Initial survey)
  • Approximately 12 weeks after completing the first survey (12-week survey)
  • Approximately 24 weeks after completing the first survey (24-week survey)

Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.

Studietyp

Interventionell

Inskrivning (Beräknad)

216

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Colorado
      • Denver, Colorado, Förenta staterna, 80205
        • Kaiser Permanente-Franklin
      • Lafayette, Colorado, Förenta staterna, 80026
        • Kaiser Permanente - Rock Creek
      • Lone Tree, Colorado, Förenta staterna, 80124
        • Kaiser Permanente - Lone Tree
    • Delaware
      • Millville, Delaware, Förenta staterna, 19967
        • Beebe South Coastal Health Campus
      • Rehoboth Beach, Delaware, Förenta staterna, 19971
        • Beebe Health Campus
    • Georgia
      • Augusta, Georgia, Förenta staterna, 30912
        • Augusta University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Förenta staterna, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • ‘Aiea, Hawaii, Förenta staterna, 96701
        • Hawaii Cancer Care - Westridge
    • Missouri
      • Osage Beach, Missouri, Förenta staterna, 65065
        • Lake Regional Hospital
      • Springfield, Missouri, Förenta staterna, 65807
        • CoxHealth South Hospital
    • New York
      • The Bronx, New York, Förenta staterna, 10461
        • Montefiore Medical Center-Einstein Campus
    • North Carolina
      • Winston-Salem, North Carolina, Förenta staterna, 27157
        • Wake Forest NCORP Research Base
    • Pennsylvania
      • Scranton, Pennsylvania, Förenta staterna, 18510
        • Community Medical Center
      • Wilkes-Barre, Pennsylvania, Förenta staterna, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
    • South Carolina
      • Gaffney, South Carolina, Förenta staterna, 29341
        • Gibbs Cancer Center-Gaffney
      • Greenville, South Carolina, Förenta staterna, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Förenta staterna, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greer, South Carolina, Förenta staterna, 29651
        • Gibbs Cancer Center-Pelham
      • Spartanburg, South Carolina, Förenta staterna, 29303
        • Spartanburg Medical Center
      • Union, South Carolina, Förenta staterna, 29379
        • MGC Hematology Oncology-Union
    • Wisconsin
      • Appleton, Wisconsin, Förenta staterna, 54911
        • ThedaCare Regional Cancer Center
      • Green Bay, Wisconsin, Förenta staterna, 54311
        • Aurora BayCare Medical Center
      • Kenosha, Wisconsin, Förenta staterna, 53142
        • Aurora Cancer Care-Kenosha South
      • Milwaukee, Wisconsin, Förenta staterna, 53215
        • Aurora Saint Luke's Medical Center
      • Neenah, Wisconsin, Förenta staterna, 54956
        • ThedaCare Regional Medical Center - Neenah

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Patient Inclusion Criteria:

  • Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
  • Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
  • Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
  • Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate

Caregiver Inclusion Criteria:

  • Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
  • Must have access to the internet at home or be willing to use CONNECT in the clinic
  • Must have access to telephone to complete sessions with the central caregiver navigator

Patient Exclusion Criteria:

  • Patients who have completed treatment for their lung cancer at the time of study enrollment
  • Enrolled in hospice care
  • Unable to read and English and not willing to have someone read surveys for them

Caregiver Exclusion Criteria:

  • Self-report currently receiving cancer treatment
  • Unable to read and communicate in English, as the CONNECT intervention is currently only available in English

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Group 1 (Standard care followed by generic resource list)

Caregivers receive standard care and are then given a generic resource list at week 24.

Receive a generic resource list

Aktiv komparator: Group 2 (Generic resource list)

Caregiver receive a generic resource list at the start of the study.

Receive a generic resource list

Experimentell: Group 3 (CONNECT, personalized list, and navigation)

Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs.

Receive personalized resource list

Receive access to CONNECT tool

Complete calls with caregiver navigator

Andra namn:
  • Patientnavigatorprogram

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Caregiver retention at 12 weeks
Tidsram: At 12 weeks

Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval.

At 12 weeks

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Caregiver accrual rate
Tidsram: Upon completion of recruitment, approximately 12 months

Number of caregivers who agree to participate divided by the number of months of recruitment

Upon completion of recruitment, approximately 12 months
Caregiver participation
Tidsram: Upon completion of recruitment, approximately 12 months

Proportion of eligible caregivers who agreed to participate

Upon completion of recruitment, approximately 12 months
Caregiver retention at 24 weeks
Tidsram: At 24 weeks

Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized.

At 24 weeks
Caregiver acceptability
Tidsram: At 12 weeks

Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much)

At 12 weeks
Average time (minutes) needed for training for Local Practice Referral Coordinator
Tidsram: At completion of training, up to 6 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

At completion of training, up to 6 months
Desired modality for training (e.g., live webinar, recorded video, paper materials) for Local Practice Referral Coordinator
Tidsram: At completion of training, up to 6 months

Will be summarized using appropriate descriptive statistics.

At completion of training, up to 6 months
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
Tidsram: At conclusion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

At conclusion of practice intervention activities, an average of 18 months
Frequency of needed resource updates in the CONNECT database
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range

Up to completion of practice intervention activities, an average of 18 months
Average time (minutes) spent by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Modality of contact (e.g. phone, virtual web meeting, email) made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Number of contacts made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Number of referrals facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Type of referrals (e.g., in person, online) facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Modalities used for communication (e.g., phone, virtual web meeting, email) for Central Caregiver Navigator and Local Practice Referral Coordinator
Tidsram: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Improvements for the future trial from Local Practice Referral Coordinator's perspectives from a survey at the end of the study
Tidsram: At completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

At completion of practice intervention activities, an average of 18 months

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Patient accrual rate
Tidsram: Upon completion of recruitment, approximately 12 months

Number of patients who agree to participate divided by the number of months of recruitment

Upon completion of recruitment, approximately 12 months
Patient participation rate
Tidsram: Upon completion of recruitment, approximately 12 months

Proportion of eligible patients who agreed to participate

Upon completion of recruitment, approximately 12 months
Patient retention at 12 weeks
Tidsram: At 12 weeks

Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized

At 12 weeks
Patient retention at 24 weeks
Tidsram: At 24 weeks

Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized

At 24 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: Kathryn Weaver, PhD, Wake Forest University Health Sciences

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

11 november 2024

Primärt slutförande (Beräknad)

30 december 2026

Avslutad studie (Beräknad)

30 december 2026

Studieregistreringsdatum

Först inskickad

15 april 2024

Först inskickad som uppfyllde QC-kriterierna

22 april 2024

Första postat (Faktisk)

25 april 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

25 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

23 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • IRB00112187
  • NCI-2023-10870 (Annan identifierare: NCI Trial Identifier)
  • Lead Organization Identifier (Annan identifierare: WF-2301CD)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.

Tidsram för IPD-delning

6 months after publication for a 2 year duration

Kriterier för IPD Sharing Access

upon request to NCORP@wakehealth.edu

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera